Skip to content
healthcare.dev

Buprenorphine and Naloxone

NDC 31722-850, Buprenorphine and Naloxone, tablet, from Camber Pharmaceuticals, Inc..

Product NDC
31722-850
Status
Listed
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
TABLET
Route
SUBLINGUAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219727
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/31722-850 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPRENORPHINE HYDROCHLORIDE2 mg/1
  • NALOXONE HYDROCHLORIDE DIHYDRATE.5 mg/1

Pharmacologic classes

Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]

Package NDCNDC-11Package
31722-850-303172208503030 TABLET in 1 BOTTLE (31722-850-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5ab2d4e4-3c8c-413a-b147-23eafbde313a

Use it

Look up 31722-850 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/31722-850 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 31722-850. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.